Systematic review on costs and resource use of randomized clinical trials shows a lack of transparent and comprehensive data

Chalmers, 2014, How to increase value and reduce waste when research priorities are set, Lancet, 383, 156, 10.1016/S0140-6736(13)62229-1 Ioannidis, 2014, Increasing value and reducing waste in research design, conduct, and analysis, Lancet, 383, 166, 10.1016/S0140-6736(13)62227-8 Salman, 2014, Increasing value and reducing waste in biomedical research regulation and management, Lancet, 383, 176, 10.1016/S0140-6736(13)62297-7 Chan, 2014, Increasing value and reducing waste: addressing inaccessible research, Lancet, 383, 257, 10.1016/S0140-6736(13)62296-5 Glasziou, 2014, Reducing waste from incomplete or unusable reports of biomedical research, Lancet, 383, 267, 10.1016/S0140-6736(13)62228-X Storz-Pfennig, 2017, Potentially unnecessary and wasteful clinical trial research detected in cumulative meta-epidemiological and trial sequential analysis, J Clin Epidemiol, 82, 61, 10.1016/j.jclinepi.2016.11.003 Morgan, 2011, The cost of drug development: a systematic review, Health Policy, 100, 4, 10.1016/j.healthpol.2010.12.002 Paul, 2010, How to improve R&D productivity: the pharmaceutical industry's grand challenge, Nat Rev Drug Discov, 9, 203, 10.1038/nrd3078 Light, 2011, Demythologizing the high costs of pharmaceutical research. The London School of Economics and Political Science, Biosocieties, 6, 1, 10.1057/biosoc.2010.40 Adams, 2006, Estimating the cost of new drug development: is it really 802 million dollars?, Health Aff (Millwood), 25, 420, 10.1377/hlthaff.25.2.420 2015 Duley, 2008, Specific barriers to the conduct of randomized trials, Clin Trials, 5, 40, 10.1177/1740774507087704 Collins, 2001, Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials, Lancet, 357, 373, 10.1016/S0140-6736(00)03651-5 DiMasi, 2016, Innovation in the pharmaceutical industry: new estimates of R&D costs, J Health Econ, 47, 20, 10.1016/j.jhealeco.2016.01.012 English, 2010 Collier, 2009, Rapidly rising clinical trial costs worry researchers, CMAJ, 180, 277, 10.1503/cmaj.082041 2015 Sinha, 2006, European move affects academic trials research, J Natl Cancer Inst, 98, 1100, 10.1093/jnci/djj349 Eisenstein, 2008, Sensible approaches for reducing clinical trial costs, Clin Trials, 5, 75, 10.1177/1740774507087551 Bosch, 2005, Europe's restrictive rules strangling clinical research, Nat Med, 11, 1260, 10.1038/nm1205-1260b Kasenda, 2014, Prevalence, characteristics, and publication of discontinued randomized trials, JAMA, 311, 1045, 10.1001/jama.2014.1361 Eisenstein, 2016, Commentary on Sertkaya et al. and Larson, et al, Clin Trials, 13, 137, 10.1177/1740774515626410 Muennig, 2015, How automation can help alleviate the budget crunch in public health research, Am J Public Health, 105, e19, 10.2105/AJPH.2015.302782 Organisation for Economic Co-operation and Development. Consumer Prices: Consumer Prices - Annual Inflation. Available at http://stats.oecd.org/index.aspx?queryid=22519#. Accessed July, 27 2017. Bloomberg. Exchange rates. Available at https://www.bloomberg.com/markets/currencies. Accessed July, 27 2017. Sertkaya, 2016, Key cost drivers of pharmaceutical clinical trials in the United States, Clin Trials, 13, 117, 10.1177/1740774515625964 Getz, 2015, Quantifying the magnitude and cost of collecting extraneous protocol data, Am J Ther, 22, 117, 10.1097/MJT.0b013e31826fc4aa Raftery, 2015, Clinical trial metadata: defining and extracting metadata on the design, conduct, results and costs of 125 randomised clinical trials funded by the National Institute for Health Research Health Technology Assessment programme, Health Technol Assess, 19, 1, 10.3310/hta19110 Zhu, 2013, The prostate, lung, colorectal, and ovarian cancer screening trial and its associated research resource, J Natl Cancer Inst, 105, 1684, 10.1093/jnci/djt281 Roche, 2002, Factors affecting workload of cancer clinical trials: results of a multicenter study of the National Cancer Institute of Canada Clinical Trials Group, J Clin Oncol, 20, 545, 10.1200/JCO.2002.20.2.545 Evans, 2000, An estimate of the cost of conducting phase II trials in lung cancer, Lung Cancer, 28, 85, 10.1016/S0169-5002(99)00132-4 Thornquist, 1993, Research cost analyses to aid in decision making in the conduct of a large prevention trial, CARET. Carotene and Retinol Efficacy Trial, Control Clin Trials, 14, 325, 10.1016/0197-2456(93)90229-7 Eri, 1992, Patient recruitment to and cost of a prospective trial of medical treatment for benign prostatic hyperplasia, Eur Urol, 22, 9, 10.1159/000474714 Kira, 2016, Recruiting pregnant indigenous women who smoke into a high contact incentivized cessation trial: a feasibility study, Nicotine Tob Res, 18, 2036, 10.1093/ntr/ntw106 Tompkins, 2015, Recruitment techniques for alcohol pharmacotherapy clinical trials: a cost-benefit analysis, Addict Disord Their Treat, 14, 211, 10.1097/ADT.0000000000000047 Gleason, 2014, Challenges in recruitment to a randomized controlled study of cardiovascular disease reduction in sleep apnea: an analysis of alternative strategies, Sleep, 37, 2035, 10.5665/sleep.4266 Krusche, 2014, An evaluation of the effectiveness of recruitment methods: the staying well after depression randomized controlled trial, Clin Trials, 11, 141, 10.1177/1740774514521905 Hapca, 2014, Effectiveness of newspaper advertising for patient recruitment into a clinical trial, Br J Clin Pharmacol, 77, 1064, 10.1111/bcp.12262 Redmond, 2013, An evaluation of the impact and costs of three strategies used to recruit acutely unwell young children to a randomised controlled trial in primary care, Clin Trials, 10, 593, 10.1177/1740774513494503 Dew, 2013, Recruitment strategy cost and impact on minority accrual to a breast cancer prevention trial, Clin Trials, 10, 292, 10.1177/1740774512471452 Penberthy, 2012, Effort required in eligibility screening for clinical trials, J Oncol Pract, 8, 365, 10.1200/JOP.2012.000646 Beauharnais, 2012, Efficacy and cost-effectiveness of an automated screening algorithm in an inpatient clinical trial, Clin Trials, 9, 198, 10.1177/1740774511434844 Graham, 2011, Efficiency and cost-effectiveness of recruitment methods for male Latino smokers, Health Educ Behav, 38, 293, 10.1177/1090198110372879 Beaton, 2010, A comparative analysis of recruitment methods used in a randomized trial of diabetes education interventions, Contemp Clin Trials, 31, 549, 10.1016/j.cct.2010.08.005 Butt, 2010, Effective and cost-effective clinical trial recruitment strategies for postmenopausal women in a community-based, primary care setting, Contemp Clin Trials, 31, 447, 10.1016/j.cct.2010.06.003 Cambron, 2010, Recruitment methods and costs for a randomized, placebo-controlled trial of chiropractic care for lumbar spinal stenosis: a single-site pilot study, J Manipulative Physiol Ther, 33, 56, 10.1016/j.jmpt.2009.11.002 Grov, 2009, Recruiting hard-to-reach drug-using men who have sex with men into an intervention study: lessons learned and implications for applied research, Subst Use Misuse, 44, 1855, 10.3109/10826080802501570 Raynor, 2009, Evaluation of active and passive recruitment methods used in randomized controlled trials targeting pediatric obesity, Int J Pediatr Obes, 4, 224, 10.3109/17477160802596189 Rodrigo, 2009, Effectiveness and cost of recruitment strategies for a community-based randomised controlled trial among rainwater drinkers, BMC Med Res Methodol, 9, 51, 10.1186/1471-2288-9-51 Walton, 2008, Screening and enrolling subjects in a randomized clinical trial involving implant dentures, Int J Prosthodont, 21, 210 Galbreath, 2008, Cumulative recruitment experience in two large single-center randomized, controlled clinical trials, Contemp Clin Trials, 29, 335, 10.1016/j.cct.2007.10.002 Sadler, 2007, Costs of recruiting couples to a clinical trial, Contemp Clin Trials, 28, 423, 10.1016/j.cct.2006.11.006 Robinson, 2007, Cost effectiveness of recruitment methods in an obesity prevention trial for young children, Prev Med, 44, 499, 10.1016/j.ypmed.2007.03.004 Perri, 2006, Monitoring recruitment success and cost in a randomized clinical trial, Eur J Prosthodont Restor Dent, 14, 126 Gismondi, 2005, Strategies, time, and costs associated with the recruitment and enrollment of nursing home residents for a micronutrient supplementation clinical trial, J Gerontol A Biol Sci Med Sci, 60, 1469, 10.1093/gerona/60.11.1469 Rubin, 2002, The Diabetes Prevention Program: recruitment methods and results, Control Clin Trials, 23, 157, 10.1016/S0197-2456(01)00184-2 MacEntee, 2002, Response to direct and indirect recruitment for a randomised dental clinical trial in a multicultural population of elders, Community Dent Oral Epidemiol, 30, 377, 10.1034/j.1600-0528.2002.00003.x Kaakko, 2001, Recruiting phobic research subjects: effectiveness and cost, Anesth Prog, 48, 3 Gill, 2001, Two recruitment strategies for a clinical trial of physically frail community-living older persons, J Am Geriatr Soc, 49, 1039, 10.1046/j.1532-5415.2001.49206.x Miller, 1999, Cost effectiveness of screening for clinical trials by research assistants versus senior investigators, J Psychiatr Res, 33, 81, 10.1016/S0022-3956(98)00045-4 Margitic, 1999, Challenges faced in recruiting patients from primary care practices into a physical activity intervention trial. Activity Counseling Trial Research Group, Prev Med, 29, 277, 10.1006/pmed.1999.0543 Bielski, 1997, Therapeutic trial participants: where do we find them and what does it cost?, Psychopharmacol Bull, 33, 75 Bjornson-Benson, 1993, Monitoring recruitment effectiveness and cost in a clinical trial, Control Clin Trials, 14, 52S, 10.1016/0197-2456(93)90024-8 Tompkins, 2015, What is the most cost-effective advertising strategy for alcohol pharmacotherapy clinical trials?, Drug Alcohol Depend, 146, e5, 10.1016/j.drugalcdep.2014.09.695 Getz, 2016, The impact of protocol amendments on clinical trial performance and cost, Ther Innov Regul Sci, 50, 436, 10.1177/2168479016632271 Getz, 2014, Improving protocol design feasibility to drive drug development economics and performance, Int J Environ Res Public Health, 11, 5069, 10.3390/ijerph110505069 Chou, 2007, The costs associated with adverse event procedures for an international HIV clinical trial determined by activity-based costing, J Acquir Immune Defic Syndr, 46, 426, 10.1097/QAI.0b013e318156ee37 Idoate, 1995, Cost-evaluation model for clinical trials in a hospital pharmacy service, Pharm World Sci, 17, 172, 10.1007/BF01879713 Funning, 2009, Quality assurance within the scope of Good Clinical Practice (GCP) - what is the cost of GCP-related activities? A survey within the Swedish Association of the Pharmaceutical Industry (LIF)'s members, Qual Assur J, 12, 3, 10.1002/qaj.433 Anguera, 2016, Conducting a fully mobile and randomised clinical trial for depression: access, engagement and expense, BMJ Innov, 2, 14, 10.1136/bmjinnov-2015-000098 Larson, 2016, Lessons learned: Infrastructure development and financial management for large, publicly funded, international trials, Clin Trials, 13, 127, 10.1177/1740774515625974 Roth, 2014, Economic return from the Women's Health Initiative estrogen plus progestin clinical trial: a modeling study, Ann Intern Med, 160, 594, 10.7326/M13-2348 Lauer, 2014, Eliminating the “expensive” adjective for clinical trials, Am Heart J, 167, 419, 10.1016/j.ahj.2013.12.003 Chit, 2014, Toward more specific and transparent research and development costs: the case of seasonal influenza vaccines, Vaccine, 32, 3336, 10.1016/j.vaccine.2013.06.055 Callaway, 2012, Chelation-therapy heart trial draws fire, Nature, 491, 313, 10.1038/491313a Light, 2009, Estimated research and development costs of rotavirus vaccines, Vaccine, 27, 6627, 10.1016/j.vaccine.2009.07.077 Baker-Smith, 2008, The economic returns of pediatric clinical trials of antihypertensive drugs, Am Heart J, 156, 682, 10.1016/j.ahj.2008.05.001 Li, 2007, Economic return of clinical trials performed under the pediatric exclusivity program, JAMA, 297, 480, 10.1001/jama.297.5.480 Drummond, 1992, Assessing the costs and benefits of medical research: the diabetic retinopathy study, Soc Sci Med, 34, 973, 10.1016/0277-9536(92)90128-D Detsky, 1989, Are clinical trials a cost-effective investment?, JAMA, 262, 1795, 10.1001/jama.1989.03430130071037 Detsky, 1985, Using economic analysis to determine the resource consequences of choices made in planning clinical trials, J Chronic Dis, 38, 753, 10.1016/0021-9681(85)90118-3 Burroughs, 1983, Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis, N Engl J Med, 309, 1539, 10.1056/NEJM198312223092502 1982, Multiple risk factor intervention trial - risk factor changes and mortality results, JAMA, 248, 1465, 10.1001/jama.1982.03330120023025 Zuidgeest, 2017, Series: pragmatic trials and real world evidence: Paper 1. Introduction, J Clin Epidemiol, 88, 7, 10.1016/j.jclinepi.2016.12.023 Sung, 2003, Central challenges facing the national clinical research enterprise, JAMA, 289, 1278, 10.1001/jama.289.10.1278 2012, Education section - studies within a trial (SWAT), J Evid Based Med, 5, 44, 10.1111/j.1756-5391.2012.01169.x DiMasi, 2003, The price of innovation: new estimates of drug development costs, J Health Econ, 22, 151, 10.1016/S0167-6296(02)00126-1 Martin, 2017, How much do clinical trials cost?, Nat Rev Drug Discov, 16, 381, 10.1038/nrd.2017.70